Literature DB >> 23043777

Ulcerative dermatitis in C57BL/6 mice lacking stearoyl CoA desaturase 1.

Lisa Krugner-Higby1, Richard Brown, Matthew Rassette, Melissa Behr, Ogi Okwumabua, Mark Cook, Cynthia Bell, Matthew T Flowers, James Ntambi, Annette Gendron.   

Abstract

Ulcerative dermatitis (UD) is a common cause of morbidity and euthanasia in mice with a C57BL/6 (B6) background. The purposes of the current study were to determine whether UD lesions could be reliably produced in B6 mice lacking stearoyl-CoA desaturase 1 (SCD1(-/-) mice), to ascertain whether the UD lesions in SCD1(-/-) mice were similar to those found in other B6 mice, and to characterize the cell invasion phenotype of Staphlococcus xylosus cultured from the lesions. S. xylosus isolates from the environment and human skin were used as controls. SCD1(-/-) (n = 8 per group) and nontransgenic B6 control mice (n = 22 mice pooled from 3 groups that received different concentrations of conjugated linoleic acid) were fed standard rodent chow or a semipurified diet (NIH AIN76A) for 4 wk. Samples from other B6 mice with UD (field cases; n = 7) also were submitted for histology and culture. All of the SCD1(-/-) mice developed UD lesions by 4 wk on NIH AIN76A. None of SCD1(-/-) fed standard rodent chow and none of the wildtype B6 mice fed NIH AIN76A developed UD. Supplementation with conjugated linoleic acid did not affect ulcerogenesis. UD lesions in SCD1(-/-) mice and field cases were grossly and histologically similar. S. xylosus was isolated from SCD1(-/-) mice with UD (71%) and field cases of UD (43%). These isolates were the most cell-invasive, followed by the environmental isolate, and finally the human skin isolate. Our results provide a basis for further pathologic and clinical study of UD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23043777      PMCID: PMC3415366     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  36 in total

1.  Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse.

Authors:  Y Zheng; K J Eilertsen; L Ge; L Zhang; J P Sundberg; S M Prouty; K S Stenn; S Parimoo
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

2.  Primary follicular dystrophy with scarring dermatitis in C57BL/6 mouse substrains resembles central centrifugal cicatricial alopecia in humans.

Authors:  J P Sundberg; D Taylor; G Lorch; J Miller; K A Silva; B A Sundberg; D Roopenian; L Sperling; D Ong; L E King; H Everts
Journal:  Vet Pathol       Date:  2010-09-22       Impact factor: 2.221

3.  Adherence by Staphylococcus intermedius to canine keratinocytes in atopic dermatitis.

Authors:  N A Mcewan
Journal:  Res Vet Sci       Date:  2000-06       Impact factor: 2.534

4.  Identification of Staphylococcus xylosus isolated from C57BL/6J-Nos2(tm1Lau) mice with dermatitis.

Authors:  Young Suk Won; Hyo Jung Kwon; Goo Taeg Oh; Bang Hyun Kim; Chul Ho Lee; Yong Ho Park; Byung Hwa Hyun; Yang Kyu Choi
Journal:  Microbiol Immunol       Date:  2002       Impact factor: 1.955

5.  Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid.

Authors:  M Miyazaki; W C Man; J M Ntambi
Journal:  J Nutr       Date:  2001-09       Impact factor: 4.798

6.  Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity.

Authors:  James M Ntambi; Makoto Miyazaki; Jonathan P Stoehr; Hong Lan; Christina M Kendziorski; Brian S Yandell; Yang Song; Paul Cohen; Jeffrey M Friedman; Alan D Attie
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

7.  Evidence that the anti-obesity effect of conjugated linoleic acid is independent of effects on stearoyl-CoA desaturase1 expression and enzyme activity.

Authors:  Kihwa Kang; Makoto Miyazaki; James M Ntambi; Michael W Pariza
Journal:  Biochem Biophys Res Commun       Date:  2004-03-12       Impact factor: 3.575

8.  The adherence of Staphylococcus aureus to human corneocytes.

Authors:  G W Cole; N L Silverberg
Journal:  Arch Dermatol       Date:  1986-02

9.  Inoculation of Staphylococcus xylosus in SJL/J mice to determine pathogenicity.

Authors:  Venita B Thornton; Judith A Davis; Mark B St Clair; Marlene N Cole
Journal:  Contemp Top Lab Anim Sci       Date:  2003-07

10.  Dexamethasone prevents granulocyte-macrophage colony-stimulating factor-induced nuclear factor-kappaB activation, inducible nitric oxide synthase expression and nitric oxide production in a skin dendritic cell line.

Authors:  Ana Luísa Vital; Margarida Gonçalo; M Teresa Cruz; Américo Figueiredo; Carlos B Duarte; M Celeste Lopes
Journal:  Mediators Inflamm       Date:  2003-04       Impact factor: 4.711

View more
  5 in total

1.  Comparison of 3 Topical Treatments against Ulcerative Dermatitis in Mice with a C57BL/6 Background.

Authors:  Carmen R Michaud; Jing Qin; William R Elkins; Alfonso S Gozalo
Journal:  Comp Med       Date:  2016-04       Impact factor: 0.982

2.  Deficiency of stearoyl-CoA desaturase-1 aggravates colitogenic potential of adoptively transferred effector T cells.

Authors:  Beng San Yeoh; Piu Saha; Vishal Singh; Xia Xiao; Yun Ying; Jairam K Vanamala; Mary J Kennett; Kevin J Harvatine; Bina Joe; Matam Vijay-Kumar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-08       Impact factor: 4.052

3.  Severe Dermatitis Associated with Spontaneous Staphylococcus xylosus Infection in Rag-/-Tpl2-/- Mice.

Authors:  Nicole V Acuff; Monica LaGatta; Tamas Nagy; Wendy T Watford
Journal:  Comp Med       Date:  2017-08-01       Impact factor: 0.982

4.  Retrospective Evaluation of Nail Trimming as a Conservative Treatment for Ulcerative Dermatitis in Laboratory Mice.

Authors:  Cynthia G Alvarado; Craig L Franklin; Lonny W Dixon
Journal:  J Am Assoc Lab Anim Sci       Date:  2016       Impact factor: 1.232

Review 5.  Systematic Literature Review of Risk Factors and Treatments for Ulcerative Dermatitis in C57BL/6 Mice.

Authors:  Jennifer L Sargent; Nathan J Koewler; Helen E Diggs
Journal:  Comp Med       Date:  2015-12       Impact factor: 0.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.